Diazaspirocycloalkane and azaspirocycloalkane

US9493486B2 · US · B2

Patent metadata
FieldValue
Publication numberUS-9493486-B2
Application numberUS-201414569564-A
CountryUS
Kind codeB2
Filing dateDec 12, 2014
Priority dateJun 13, 2012
Publication dateNov 15, 2016
Grant dateNov 15, 2016

How to read this patent

A practical reading order for non-experts. Skip the full description unless you need deep technical detail.

  1. Title

    What the patent document calls the invention.

  2. Abstract

    A short plain-language summary of the technical disclosure.

  3. Assignees and inventors

    Who owns or filed the patent and who is credited as inventor.

  4. Key dates

    Filing, priority, publication, and grant dates set the timeline.

  5. First independent claim

    The legal scope of protection — read this for what is actually claimed.

  6. CPC / IPC classifications

    Technology tags used to group this patent with similar filings.

  7. Citations and related patents

    Prior art links and similar publications in this corpus.

Abstract

Official abstract text for this publication.

The invention provides novel compounds having the general formula (I) wherein R 1 , R 2 , Y and W are as described herein, compositions including the compounds and methods of using the compounds.

First claim

Opening claim text (preview).

The invention claimed is: 1. A compound of formula (I) wherein R 1 is phenylalkyl substituted with R 8 , R 9 and R 10 ; R 2 is —C(O)—R 3 ; Y is —OC(O)—; W is R 3 is; and R 8 , R 9 , and R 10 are independently selected from H, alkyl, hydroxyalkyl, haloalkyl, cycloalkyl, cycloalkylalkyl, cycloalkylalkoxy, cycloalkoxy, cycloalkoxyalkyl, cycloalkylalkoxyalkyl, alkoxy, alkoxyalkyl, haloalkoxy, haloalkoxyalkyl, alkoxyalkoxy, alkoxyalkoxyalkyl, halogen, hydroxy, cyano, alkylsulfonyl, cycloalkylsulfonyl, substituted aminosulfonyl, substituted amino and substituted aminoalkyl, wherein substituted aminosulfonyl, substituted amino and substituted aminoalkyl are substituted on the nitrogen atom with one to two substituents independently selected from hydrogen, alkyl, cycloalkyl, cycloalkylalkyl, hydroxyalkyl, alkoxyalkyl, alkylcarbonyl and cycloalkylcarbonyl; or a pharmaceutically acceptable salt thereof. 2. A The compound of claim 1 , wherein R 8 is haloalkoxy, halogen or alkylsulfonyl. 3. A The compound of claim 1 , wherein R 9 is alkyl, haloalkyl or halogen. 4. The compound of claim 1 , wherein R 10 is H. 5. The compound of claim 1 , selected from: 6. The compound of claim 5 , selected from:

Assignees

Inventors

Classifications

  • Immunosuppressants, e.g. drugs for graft rejection · CPC title

  • Antineoplastic agents · CPC title

  • Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID] · CPC title

  • Drugs for disorders of the nervous system · CPC title

  • of the kidneys · CPC title

Patent family

Related publications grouped by family.

External sources

Frequently asked questions

Answers are generated from the same data shown on this page.

What does patent US9493486B2 cover?
The invention provides novel compounds having the general formula (I) wherein R 1 , R 2 , Y and W are as described herein, compositions including the compounds and methods of using the compounds.
Who is the assignee on this patent?
Hoffmann La Roche, Hoffmann-La Roches Inc
What technology area does this patent fall under?
Primary CPC classification C07D471/10. Mapped technology areas include Chemistry & Metallurgy.
When was this patent published?
Publication date Tue Nov 15 2016 00:00:00 GMT+0000 (Coordinated Universal Time) (B2). Legal status and post-grant events are not shown on this page.
What related patents are in patentsdb?
We list 8 related publications on this page (citations in our corpus or others sharing the same primary CPC).